{"id":"https://openalex.org/W2563029157","doi":"https://doi.org/10.1182/blood.v120.21.2887.2887","title":"BMS-936564 (MDX1338): A Fully Human Anti-CXCR4 Antibody Induces Apoptosis in an in Vitro Model of Stromal \u2013 Leukemia Cell Interaction for Chronic Lymphocytic Leukemia.","display_name":"BMS-936564 (MDX1338): A Fully Human Anti-CXCR4 Antibody Induces Apoptosis in an in Vitro Model of Stromal \u2013 Leukemia Cell Interaction for Chronic Lymphocytic Leukemia.","publication_year":2012,"publication_date":"2012-11-16","ids":{"openalex":"https://openalex.org/W2563029157","doi":"https://doi.org/10.1182/blood.v120.21.2887.2887","mag":"2563029157"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v120.21.2887.2887","doi":"https://doi.org/10.1182/blood.v120.21.2887.2887","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.2887.2887","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067776068","display_name":"Manoj Kumar Kashyap","orcid":"https://orcid.org/0000-0002-3064-8452","observed_orcids":["https://orcid.org/0000-0002-3064-8452"]},"institutions":[{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Manoj Kumar Kashyap","raw_affiliation_strings":["Moores Cancer center, University of California, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moores Cancer center, University of California, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080395400","display_name":"Deepak Kumar","orcid":"https://orcid.org/0000-0001-6298-3565","observed_orcids":["https://orcid.org/0000-0001-6298-3565","https://orcid.org/0009-0002-5314-975X","https://orcid.org/0009-0009-6555-4657"]},"institutions":[{"id":"https://openalex.org/I2803209242","display_name":"University of California System","ror":"https://ror.org/00pjdza24","country_code":"US","type":"education","lineage":["https://openalex.org/I2803209242"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Deepak Kumar","raw_affiliation_strings":["University of California,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California,","institution_ids":["https://openalex.org/I2803209242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021841372","display_name":"Harrison Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2803209242","display_name":"University of California System","ror":"https://ror.org/00pjdza24","country_code":"US","type":"education","lineage":["https://openalex.org/I2803209242"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harrison Jones Jones","raw_affiliation_strings":["University of California,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California,","institution_ids":["https://openalex.org/I2803209242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075436982","display_name":"Michael Y. Choi","orcid":"https://orcid.org/0000-0002-9107-2186","observed_orcids":["https://orcid.org/0000-0002-9107-2186"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Y. Choi","raw_affiliation_strings":["Medicine, Moores UCSD Cancer Center, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Moores UCSD Cancer Center, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047903125","display_name":"Johanna Melo\u2010Cardenas","orcid":"https://orcid.org/0000-0002-5122-3349","observed_orcids":["https://orcid.org/0000-0002-5122-3349"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Johanna Melo-Cardenas","raw_affiliation_strings":["Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, UCSD, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, UCSD, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040742407","display_name":"Michelle R. Kuhn\u00e9","orcid":"https://orcid.org/0009-0007-4987-7654","observed_orcids":["https://orcid.org/0009-0007-4987-7654"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle R. Kuhne","raw_affiliation_strings":["Biologics Discovery California, Bristol-Myers Squibb, Sunnyvale, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biologics Discovery California, Bristol-Myers Squibb, Sunnyvale, CA, USA,","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034712498","display_name":"Peter Sabbatini","orcid":"https://orcid.org/0009-0007-8244-3700","observed_orcids":["https://orcid.org/0009-0007-8244-3700"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Peter Sabbatini","raw_affiliation_strings":["Bristol-Myers Squibb,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb,","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054535169","display_name":"Lewis J. Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lewis Cohen","raw_affiliation_strings":["Discovery Medicine, Bristol-Myers Squibb, Princeton, NJ, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Medicine, Bristol-Myers Squibb, Princeton, NJ, USA,","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040710269","display_name":"Suresh G. Shelat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suresh Shelat","raw_affiliation_strings":["Bristol-Myers Squibb, Sunnyvale, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Sunnyvale, USA,","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075129793","display_name":"Pina M. Cardarelli","orcid":"https://orcid.org/0000-0001-8898-761X","observed_orcids":["https://orcid.org/0000-0001-8898-761X"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Pina M Cardarelli","raw_affiliation_strings":["Biologics Discovery California, Bristol-Myers Squibb, Sunnyvale, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biologics Discovery California, Bristol-Myers Squibb, Sunnyvale, CA, USA,","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Kipps","raw_affiliation_strings":["Division of Hematology-Oncology and Central Office of CLL Research Consortium, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology and Central Office of CLL Research Consortium, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013814515","display_name":"Januario E. Castro","orcid":"https://orcid.org/0000-0003-2785-0892","observed_orcids":["https://orcid.org/0000-0003-2785-0892"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Januario E. Castro","raw_affiliation_strings":["Moores UCSD Cancer Center, CLL Research Consortium, La Jolla, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moores UCSD Cancer Center, CLL Research Consortium, La Jolla, CA, USA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5034712498","https://openalex.org/A5047903125","https://openalex.org/A5067776068","https://openalex.org/A5075129793","https://openalex.org/A5080395400"],"corresponding_institution_ids":["https://openalex.org/I2803209242","https://openalex.org/I36258959","https://openalex.org/I4210091812","https://openalex.org/I4390039236"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.1444,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.55941377,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"120","issue":"21","first_page":"2887","last_page":"2887"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/cxcl12","display_name":"CXCL12","score":0.8949999809265137},{"id":"https://openalex.org/keywords/cxcr4","display_name":"CXCR4","score":0.8960000276565552},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5950000286102295},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7480000257492065},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7129999995231628},{"id":"https://openalex.org/keywords/f-actin-polymerization","display_name":"F-actin polymerization","score":0.796999990940094},{"id":"https://openalex.org/keywords/amd3100","display_name":"AMD3100","score":0.859000027179718}],"concepts":[{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.7981076240539551},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.7536725997924805},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6162630319595337},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5782665610313416},{"id":"https://openalex.org/C129470790","wikidata":"https://www.wikidata.org/wiki/Q415718","display_name":"CXCR4","level":4,"score":0.49853038787841797},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4898471534252167},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.47955748438835144},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.475496381521225},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.435157835483551},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.4332771897315979},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38986068964004517},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26869773864746094},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.2666676640510559},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.16705390810966492},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.09341630339622498},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v120.21.2887.2887","doi":"https://doi.org/10.1182/blood.v120.21.2887.2887","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.2887.2887","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2560756697","https://openalex.org/W1976767301","https://openalex.org/W2046125843","https://openalex.org/W104449324","https://openalex.org/W2266192831","https://openalex.org/W2614273416","https://openalex.org/W2102089654","https://openalex.org/W2563996350","https://openalex.org/W2128289246","https://openalex.org/W2552055939"],"abstract_inverted_index":{"Abstract":[0,1],"2887":[2],"Chronic":[3],"lymphocytic":[4],"leukemia":[5,109,298,325],"(CLL)":[6],"remains":[7],"incurable":[8],"despite":[9],"advances":[10],"in":[11,35,97,126,187,226,246,270,291,297,307,376,387],"the":[12,22,43,57,76,85,119,177,188,279,288,332,338,345,368],"biology":[13],"and":[14,117,228,294,327,378,389],"treatment":[15,206],"of":[16,45,79,87,101,121,173,179,181,190,287,303,340,344,347,358],"this":[17,318],"disease.":[18],"Current":[19],"data":[20],"support":[21],"notion":[23],"that":[24,41,130,168,195,213,223,229,278,317,328,355,367],"resistance":[25,44,120,162],"to":[26,48,69,124,163,205,232,254],"therapy":[27],"is":[28,56,360,371],"promoted":[29],"by":[30],"a":[31,89,236,257,372],"\u201cprotective\u201d":[32],"tumor":[33,334],"microenvironment":[34],"which":[36,60],"non-leukemia":[37],"cells":[38,47,68,107,114,123,133,137,144,155,159,183,194,212,222,248,272,293,308,315,326],"produce":[39],"factors":[40,350],"enhance":[42,118,176],"CLL":[46,67,122,132,143,154,182,193,211,221,247,271,292,377,388],"spontaneous":[49],"or":[50,186,200,311],"drug-induced":[51,164],"apoptosis.":[52,165],"One":[53],"such":[54,235,351],"factor":[55],"chemokine":[58],"CXCL12,":[59],"interacts":[61],"with":[62,135,157,207,313],"its":[63,356],"receptor":[64,290],"CXCR4":[65,260,289],"on":[66,324],"promote":[70],"cancer":[71],"cell":[72,110],"survival.":[73],"To":[74],"examine":[75],"therapeutic":[77,374],"potential":[78],"blocking":[80],"CXCL12-CXCR4":[81],"interactions,":[82],"we":[83,276],"studied":[84],"effect":[86,323],"BMS-936564,":[88],"fully":[90],"human":[91,102],"IgG4":[92],"anti-CXCR4":[93,280],"antibody,":[94],"using":[95,393],"an":[96],"vitro":[98],"co-culture":[99],"model":[100],"bone":[103],"marrow":[104],"derived":[105],"stomal-NKter":[106],"\u2013":[108],"interaction.":[111],"Such":[112],"stromal-NKter":[113,136],"secrete":[115],"CXCL12":[116,242,284],"apoptosis":[125,180,269,296],"vitro.":[127],"We":[128,166],"observed":[129,277,306],"primary":[131],"co-cultured":[134,156],"had":[138,160,320],"significantly":[139],"greater":[140],"viability":[141],"than":[142],"cultured":[145,184,309],"alone":[146,185,310],"(20\u201360%":[147],"above":[148],"baseline":[149],"at":[150,171,249],"48":[151],"hours).":[152],"Moreover,":[153],"stromal":[158,191,314],"enhanced":[161],"found":[167],"BMS-936564":[169,208,239,282,304,341],"antibody":[170,240,281,319],"concentrations":[172,251],"2\u2013200nM":[174],"could":[175],"rate":[178],"presence":[189,346],"cells.":[192,299],"expressed":[196],"unmutated":[197],"IgVH":[198],"genes":[199],"ZAP-70":[201],"appeared":[202],"equally":[203],"susceptible":[204],"as":[209,219,352],"did":[210,220,266],"lack":[214],"these":[215],"adverse":[216],"prognostic":[217,349],"markers,":[218],"harbored":[224],"deletions":[225],"17p13.2":[227],"were":[230],"resistant":[231],"chemotherapeutic":[233],"agents,":[234],"fludarabine":[237],"monophosphate.":[238],"inhibited":[241,283],"mediated":[243,285],"F-Actin":[244],"polymerization":[245],"lower":[250],"(20\u2013200nM)":[252],"compared":[253],"AMD-3100":[255,265],"(Mozobil),":[256],"small":[258],"molecule":[259],"inhibitor":[261],"(50\u2013150\u03bcM).":[262],"In":[263,274],"addition,":[264],"not":[267],"induce":[268],"(10\u2013300\u03bcM).":[273],"summary,":[275],"activation":[286],"induced":[295],"The":[300],"pro-apoptotic":[301],"activity":[302,339],"was":[305,342],"together":[312],"suggesting":[316,354],"direct":[321],"cytotoxic":[322],"it":[329],"can":[330],"overcome":[331],"protective":[333],"microenvironment.":[335],"More":[336],"over,":[337],"independent":[343],"poor":[348],"del(17p)":[353],"mechanism":[357],"action":[359],"P53":[361],"independent.":[362],"These":[363],"findings":[364],"show":[365],"evidence":[366],"CXCR4-CXCL12":[369],"pathway":[370],"valid":[373],"target":[375],"provide":[379],"additional":[380],"biological":[381],"rationale":[382],"for":[383],"ongoing":[384],"clinical":[385],"trials":[386],"other":[390],"hematological":[391],"malignancies":[392],"BMS-936564.":[394],"Disclosures:":[395],"Kuhne:":[396],"Bristol-Myers":[397],"Squibb:":[398,401,404,407,410],"Employment.":[399,402,405,408,411],"Sabbatini:Bristol-Myers":[400],"Cohen:Bristol-Myers":[403],"Shelat:Bristol-Myers":[406],"Cardarelli:Bristol-Myers":[409],"Kipps:Abbott:":[412],"Consultancy,":[413],"Research":[414],"Funding.":[415]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-01-06T00:00:00"}